Product Introduction
Lomela 2/0.1/0.025% Cream is a topical formulation combining three active ingredients:
Hydroquinone (2%): A skin-lightening agent that reduces melanin production, helping to fade dark spots and hyperpigmentation.​
Mometasone Furoate (0.1%): A corticosteroid that alleviates inflammation, redness, and itching associated with skin conditions.​
Tretinoin (0.025%): A retinoid that accelerates skin cell turnover, promoting the shedding of pigmented skin cells and revealing fresher skin.​
This combination is primarily used to treat melasma, a condition characterized by dark, discolored patches on the skin, often due to hormonal changes, sun exposure, or skin injuries. Lomela Cream works synergistically to lighten these patches, reduce inflammation, and promote skin renewal.​
Uses
- Treatment of melasma and other forms of hyperpigmentation.​
- Management of dark spots caused by sun exposure, pregnancy, or oral contraceptive use.​
- Reduction of skin discoloration and improvement in skin tone.​
Benefits
- Effective Pigmentation Reduction: Hydroquinone lightens dark spots, evening out skin tone.​
- Anti-Inflammatory Action: Mometasone reduces redness, swelling, and irritation.​
- Enhanced Skin Renewal: Tretinoin promotes faster skin cell turnover, aiding in the removal of pigmented cells.​
- Improved Skin Texture: Regular use can lead to smoother and more radiant skin.​
Composition
- Hydroquinone: 2%​
- Mometasone Furoate: 0.1%​
- Tretinoin: 0.025%​
Side Effects
Common side effects may include:
- Burning or stinging sensation at the application site.​
- Redness and irritation.​
- Dryness or peeling of the skin.​
- Increased sensitivity to sunlight.​​
Safety Advice
- Sun Protection: Use sunscreen and protective clothing to prevent further pigmentation.​
- Application: Apply a thin layer to the affected area once daily, preferably at night.​
- Avoid Sensitive Areas: Do not apply near the eyes, mouth, or mucous membranes.​
- Pregnancy and Breastfeeding: Consult your doctor before use during pregnancy or breastfeeding.​
- Children: Not recommended for use in children under 12 years of age.​
